Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir

IMPORTANCE: Some patients treated with nirmatrelvir-ritonavir have experienced rebound of COVID-19 infections and symptoms; however, data are scarce on whether viral rebound also occurs in patients with COVID-19 receiving or not receiving molnupiravir. OBJECTIVE: To examine the incidence of viral re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Grace Lai-Hung, Yip, Terry Cheuk-Fung, Lai, Mandy Sze-Man, Wong, Vincent Wai-Sun, Hui, David Shu-Cheong, Lui, Grace Chung-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856258/
https://www.ncbi.nlm.nih.gov/pubmed/36472873
http://dx.doi.org/10.1001/jamanetworkopen.2022.45086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856258/
https://www.ncbi.nlm.nih.gov/pubmed/36472873
http://dx.doi.org/10.1001/jamanetworkopen.2022.45086

Ejemplares similares